Nebivolol Hydrochloride; Valsartan is Used for managing high blood pressure. It was first introduced by Abbvie Inc in its drug Byvalson on Jun 3, 2016. 2 different companies have introduced drugs containing Nebivolol Hydrochloride; Valsartan.

Nebivolol Hydrochloride; Valsartan Patents

Given below is the list of patents protecting Nebivolol Hydrochloride; Valsartan, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Byvalson	US7838552	Compositions comprising nebivolol	Oct 04, 2027	Abbvie
Byvalson	US7803838	Compositions comprising nebivolol	Aug 29, 2026	Abbvie

Add above patents to watchlist

Nebivolol Hydrochloride; Valsartan's Family Patents

Full family tree

Nebivolol Hydrochloride; Valsartan Generic API Manufacturers

Only one generic application has been filed for Nebivolol Hydrochloride; Valsartan.

Given below is the list of companies who have filed for Nebivolol Hydrochloride; Valsartan generic, along with the locations of their manufacturing plants worldwide.